Rituximab in connective tissue disease–associated interstitial lung disease

2019 
Introduction/objectives To evaluate rituximab (RTX) effectiveness and safety in patients with interstitial lung disease (ILD) related to connective tissue diseases (CTD).
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    46
    References
    19
    Citations
    NaN
    KQI
    []